The Pathophysiology of Circulating Immune Complexes: Their Role in Host-Tumor Interactions and Removal by Immunoadsorption Therapy

  • Terence M. Phillips
  • Thomas V. Holohan
  • Stefan Korac
  • Newton S. More
  • William D. Queen
Part of the Contemporary Topics in Immunobiology book series (CTI, volume 15)


Circulating immune complexes (CIC) have received much attention during the past few years, and many different techniques have been devised to measure and isolate them. As our knowledge of immunology has expanded, so has our understanding of these entities, which in reality are aggregates of floating immunological debris, having the potential not only to cause damage to a number of different organs but also to play a role in immune regulation.


Systemic Lupus Erythematosus Immune Complex Thrombotic Thrombocytopenic Purpura Circulate Immune Complex Immune Complex Deposition 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Aikawa, T., Mitamura, T., Tanimoto, K., and Horiudri, Y., 1979, Detection of circulating immune complexes by using human red blood cells, J. Lab. Clin. Med. 94: 902.PubMedGoogle Scholar
  2. Amlot, P.L., Pussell, B., Slaney, J.M., and Williams, B.D., 1976, Correlation between immune complexes and prognostic factors in Hodgkin’s disease, Clin. Exp. Immunol 31: 166.Google Scholar
  3. Andrews, B.S., Mcintosh, J., Petts, V., and Penny, R., 1977, Circulating immune complexes in retinal vasculitis, Clin. Exp. Immunol. 29: 23.PubMedGoogle Scholar
  4. Aoki, T., Walling, M.J., Bushar, G.S., Liu, M., and Hsu, K.C., 1976, Natural antibodies in sera from healthy humans to antigens on surfaces of type C RNA viruses and cells from primates, Proc. Natl Acad. Sci. USA 73: 2491.PubMedGoogle Scholar
  5. Atkins, C.J., Kondon, J.J., Quismorio, FP., and Friou, G.J., 1972, The choroid plexus in systemic lupus erythematosus, Ann. Intern. Med. 76: 65.PubMedGoogle Scholar
  6. Baldwin, R.W., and Robins, R.A., 1975, Humoral factors abrogating cell-mediated immunity in the tumour-bearing host, Curr. Topics Microbiol Immunol. 72: 21.Google Scholar
  7. Bansal, S.C., and Sjogren, H.O., 1971, Unblocking serum activity in-vitro in the polyoma system may correlate with antitumor effects of antiserum in-vivo, Nature New Biol 233: 76.PubMedGoogle Scholar
  8. Bansal, S.C., Bansal, B.R., and Boland, J.P., 1976, Blocking and unblocking serum factors in neoplasia, Curr. Topics Microbiol Immunol 75: 45.Google Scholar
  9. Bansal, S.C., Bansal, B.R., Rhoads, J. E., Cooper, D. R., Boland, J.P., and Mark, E., 1978a, Ex-vivo removal of mammalian immunoglobulin G: Method and immunological alterations, Int. J. Artif. Organs 1: 94.PubMedGoogle Scholar
  10. Bansal, S.C., Bansal, B.R., Thomas, H.L., Siegel, P.D., Rhoads, J.E., Cooper, D.R.,Terman, D.S., and Mark, E., 1978b, Ex-vivo removal of serum IgG in a patient with colon carcinoma, Cancer 42: 1.PubMedGoogle Scholar
  11. Bartfield, H., 1969, Distribution of rheumatoid factor activity in nonrheumatoid states, Ann N. Y. Acad. Sci. 168: 126.Google Scholar
  12. Beatty, P.G., Kim, B.S., Rowley, D.A., and Coppleston, L.W., 1976, Antibody against the antigen receptor of a plasmacytoma prolongs survival of mice bearing the tumor, J. Immunol 116: 1391.PubMedGoogle Scholar
  13. Browne, O., Bell, J., Holland, P., and Thornes, R., 1976, Plasmapheresis and immunostimulation, Lancet 2: 96.PubMedGoogle Scholar
  14. Cantrell, J.E., Phillips, T.M., Smith, F.P., and Schein, P.S., 1982, Immune complex analysis and plasmapheresis in cancer related thrombotic thrombocytopenic purpura (TTP)/ hemolytic uremic syndrome (HUS), Blood 60: 185a.Google Scholar
  15. Carpentier, N.A., Fiere, D.M., Schuh, D., Lange, G.T., and Lambert, P.H., 1982, Circulating immune complexes and the prognosis of acute myeloid leukemia, N. Engl. J. Med. 307: 1174.PubMedGoogle Scholar
  16. Chollet, P., Carpentier, N., Chassagne, G., Betail, J.M., Bidet, P.H., Lambert, P.H., and Plagne, R., 1980, Clinical relevance of circulating immune complexes in breast cancer, in: International Symposium on New Trends in Human Immunology and Cancer Immunotherapy ( B. Serrou and C. Rosenfeld, eds.), pp. 496–503, Dion/Saunders, Paris.Google Scholar
  17. Cochrane, C. G., and Dixon, F. J., 1976, Antigen-antibody complex induced disease, in: Textbook of Immunopathology ( P. A. Miescher and H. J. Muller-Eberhard, eds.), pp. 137–156, Grune and Stratton, New York.Google Scholar
  18. Cochrane, C. G., and Koffler, D., 1973, Immune complex disease in experimental animals and man, Adv. Immunol 16: 185.PubMedGoogle Scholar
  19. Cornacoff, J. B., Zager, R. A., and Herbert, L. A., 1981, Mechanisms of binding of immune complexes to human erythrocytes, Clin. Res. 29: 364A.Google Scholar
  20. Cotropia, J.P., Gutterman, J. U., Hersh, E. M., Granatek, C. H., and Mavligit, G. M., 1976, Antigen expression and cell surface properties of human leukemia blasts, Ann. N. Y. Acad Sci 276: 146.PubMedGoogle Scholar
  21. Davies, G. E., and Lowe, J. S., 1960, A permeability factor released from guinea pig serum by antigen-antibody precipitates, Br. J. Exp. Pathol. 41: 335.PubMedGoogle Scholar
  22. Deisseroth, A., and Holohan, T.V., 1980, Extracorporeal immunoadsorption of plasma in cancer patients employing Cowan I S. aureus, Initial Proposal of Clinical Research Project Protocol, COP, DCT, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.Google Scholar
  23. Dixon, F.J., 1963, The role of antigen-antibody complexes in disease, Harvey Lect. 58: 21.PubMedGoogle Scholar
  24. Dixon, F.J., Feldman, J.D., and Vazquez, J.J., 1961, Experimental glomerulonephritis: The pathogenesis of a laboratory model resembling the spectrum of human glomerulonephritis, J. Exp. Med. 113: 899.PubMedGoogle Scholar
  25. Dosa, S., Phillips, T. M., Segal, A., Guha, A., and Thompson, A. M., 1983, Acute myeloblasts leukemia associated with nephrotic syndrome: An immunochemical study, Nephron 34: 125.PubMedGoogle Scholar
  26. Eagan, J. W., Roberts, J. L., Schwartz, M. M., and Lewis, E. J., 1979, The composition of pulmonary immune deposits in systemic lupus erythematosus, Clin. Immunol. Immunopathol. 12: 204.Google Scholar
  27. Eichmann, K., 1978, Expression and function of idiotypes on lymphocytes, Adv. Immunol. 26: 195.PubMedGoogle Scholar
  28. Eichmann, K., and Rajewsky, K., 1975, Induction of T and B cell immunity by anti-idiotypic antibody, Eur. J. Immunol 5: 661.PubMedGoogle Scholar
  29. Eisen, V., and Smith, H. G., 1963, Plasma kinin formation by complexes of aggregated gamma globulin and serum proteins, Br. J. Exp. Pathol. 51: 328.Google Scholar
  30. Fairley, G. H., 1969, Immunity to malignant disease, Br. Med J. 1: 467.Google Scholar
  31. Fearon, D. T., 1980, Identification of the membrane glycoprotein that is the C3b receptor of the human erythrocytes, polymorphonuclear leucocytes, B lymphocytes and monocytes, J. Exp. Med. 152: 20.PubMedGoogle Scholar
  32. Ferrone, S., and Pellegrino, M. A., 1978, Antigens and antibodies in malignant melanoma, in: The Handbook of Cancer Immunology ( H. Waters, ed.), pp. 291–328, Garland STPM Press, New York.Google Scholar
  33. Forsgren, A., and Sjoquist, J., 1966, Pseudo-immune reaction with human gamma globulin, J. Immunol 97: 822.PubMedGoogle Scholar
  34. Gauci, L.,Caraux, J.,Cupissol, D.,and Serrou,B., 1980, The relationship between circulating immune complexes and cellular immunity in cancer patients, in: International Symposium on New Trends in Human Immunology and Cancer Immunotherapy ( B. Serrou and C. Rosenfeld, eds.), pp. 504–520, Dion/Saunders, Paris.Google Scholar
  35. Gauci, L., Caraux, J., and Serrou, B., 1981, Immune complexes in the context of the immune response in cancer patients, in Human Cancer Immunology: Immune Complexes and Plasma Exchanges in Cancer Patients ( B. Serrou and C. Rosenfeld, eds.), Vol. 1, pp. 37–98, Elsevier/North-Holland, Amsterdam.Google Scholar
  36. Germuth, F. G., 1953, A comparative histologic and immunologic study in rabbits of induced hypersensitivity of the serum sickness type, J. Exp. Med 97: 257.PubMedGoogle Scholar
  37. Gigli, I., Kaplan, A. P., and Austen, K. F., 1971, Modulation of function of the activated first component of complement by a fragment derived from serum, J. Exp. Med. 134: 1466.PubMedGoogle Scholar
  38. Gordon, B.R., Moroff, S., Hurvitz, A. T., Matas, R. E., MacEwen, E. G., Good, R. A., and Day, N. K., 1980, Circulating immune complexes in sera of dogs with benign and malignant breast disease, Cancer. Res. 40: 3627.PubMedGoogle Scholar
  39. Hartmann, D. P., 1976, The identification and role of antiimmunoglobulin in human malignancy, Ph.D. Thesis, McGill University, Montreal, Canada.Google Scholar
  40. Hellström, I., and Hellström, K. E., 1969, Colony-inhibition studies on blocking and non- blocking serum effects on cellular immunity in Moloney sarcoma, Int. J. Cancer 5: 159.Google Scholar
  41. Hellström, K. E., Hellström, I., and Nepom, J. T., 1977, Specific blocking factors-Are they important? Biochem. Biophys. Acta Rev. Cancer 473: 121.Google Scholar
  42. Hersey, P., Edwards, A., Adams, E., Isbister, J.P., Murrey, E., Biggs, J. C., and Milton, G.W., 1976, Antibody-dependent cell-mediated cytotoxicity against melanoma cells induced by plasmapheresis, Lancet 1: 825.PubMedGoogle Scholar
  43. Holohan, T. V., Phillips, T. M., Bowles, C., and Deisseroth, A., 1982, Regression of canine mammary carcinoma after immunoadsorption therapy, Cancer Res. 42: 3663.PubMedGoogle Scholar
  44. Hubbard, R. A., Aggio, M. C., Lozzio, B. B., and Wust, D. J., 1981, Correlation of circulating immune complexes and disease status in patients with leukemia, Clin. Exp. Immunol. 43: 46.PubMedGoogle Scholar
  45. Huber, S., and Lucas, Z., 1978, Immune response to a mammary adenocarcinoma. V. Sera from tumor-bearing rats contain multiple factors blocking cell-mediated immunity, J. Immunol 121: 2485.PubMedGoogle Scholar
  46. Humphrey, J. H., and Jaques, R., 1955, The release of histamine and 5-HT (serotonin) from platelets by antigen-antibody reactions (in vitro), J. Physiol. 128: 9.PubMedGoogle Scholar
  47. Jerne, N. K., 1974, Immune regulation in a lymphocyte network, in: Cellular Selection and Regulation in the Immune Response ( G. M. Edelman, ed.), pp. 39–45, Raven Press, New York.Google Scholar
  48. Jerry, L. M., Rowden, G., Cano, P. O., Phillips, T. M., Deutsch, G. F., Capek, A., Hartmann, D., and Lewis, M. G., 1976, Immune complexes in human melanoma: A consequence of deranged immune regulation, Scand. J. Immunol. 5: 845.PubMedGoogle Scholar
  49. Jewell, D. P., and MacLennan, I.C. M., 1973, Circulating immune complexes in inflammatory bowel disease, Clin. Exp. Immunol. 14: 219.PubMedGoogle Scholar
  50. Jones, F. R., Yoshida, L. H., Ladiges, W. C., and Kenny, M. A., 1980, Treatment of feline leukemia and reversal of FeLV by ex-vivo removal of IgG: A preliminary report, Cancer 46: 675.PubMedGoogle Scholar
  51. Jones, L. W., Levin, A., and Fudenberg, H. H., 1975, Glomerular antigen complexes associated with transitional cell carcinoma, Surg. Gynecol. Obstet. 140: 896.PubMedGoogle Scholar
  52. Jose, D. G., and Seshada, R., 1974, Circulating immune complexes in human neuroblastoma: Direct assay and role in blocking specific cellular immunity, Int. J. Cancer 13: 824.PubMedGoogle Scholar
  53. Kaplan, A. P., Spragg, J., and Austen, K. F., 1971, The bradykinin forming system of man, in: Biochemistry of the Acute Allergic Reaction ( K. F. Austem and E. L. Becker, eds.), pp. 279–302, Blackwell, Oxford.Google Scholar
  54. Kessler, S. W., 1975, Rapid isolation of antigens from cells with a staphylococcal protein A antibody adsorbent: Parameters of the interaction of antibody-antigen complexes with protein A, J. Immunol. 115: 1617.PubMedGoogle Scholar
  55. Klaus, G. G. B., 1979, Cooperation between antigen-reactive T cells and anti-idiotypic responses to antigen-antibody complexes, Nature 278: 354.PubMedGoogle Scholar
  56. Klein, G., 1971, Immunological studies on human tumors: Dilemmas of the experimentalist, Isr. J. Med. Sci 7: 111.PubMedGoogle Scholar
  57. Klein, G., 1984, Induction, expression, and manipulation of immunity to tumors: A summary, in: Progress in Immunology, Vol. 5 ( Y. Yamamura and T. Tada, eds.), pp. 1269–1275, Academic Press, New York.Google Scholar
  58. Kölsch, E., Oberbarnscheidt, J., Bruner, K., and Heure, J., 1980, The Fc-receptor: Its role in the transmission of differentiation signals, Immunol. Rev. 49: 61.PubMedGoogle Scholar
  59. Korac, S., Smith, F. P., Schein, P. S., and Phillips, T. M., 1984, Clinical experience with extra-corporeal immunoperfusion of plasma from cancer patients, J. Biol. Resp. Modif. 3: 330.Google Scholar
  60. Kremer, W. B., and Laszlo, A., 1974, Hematologic effects of cancer, in: Cancer Medicine ( J. Holland and E. Freii, eds.), pp. 1085–1090, Lea and Febiger, Philadelphia.Google Scholar
  61. Kronval, T., Applebaum, E., Popovic, D., Gill, L., Sisson, G., Wood, G., and Anderson, B., 1977, Demonstration of immunoglobulin in tumor and marginal tissues of squamous cell carcinomas of the head and neck, J. Natl. Cancer Inst. 59: 1089.Google Scholar
  62. Langone, J. J., Das, C., Bennett, D., and Terman, D. S., 1983, Radioimmunoassays for protein A of Staphylococcus aureus, J. Immunol. Methods 63: 145.PubMedGoogle Scholar
  63. Langvad, E., Hyden, H., Wolf, H., and Kroeigaard, N., 1975, Extracorporeal immunoadsorption of circulating specific serum factors in cancer patients, Br. J. Cancer 32: 680.PubMedGoogle Scholar
  64. Lewis, M. G., Ikonopisov, R. L., Nairn, R. C., Phillips, T. M., Hamilton Fairley,G., Bodenham, D. C., and Alexander, P., 1969, Tumour-specific antibodies in human malignant melanoma and their relationship to the extent of the disease, Br. Med. J. 3: 547.PubMedGoogle Scholar
  65. Lewis, M. G., Loughridge, L. W., and Phillips, T. M., 1971, Immunological studies on a patient with the nephrotic syndrome associated with malignancy of non-renal origin, Lancet 2: 134.PubMedGoogle Scholar
  66. Lewis, M. G., Hartmann, D., and Jerry, L. M., 1976, Antibodies and anti-antibodies inhuman malignancy: An expression of deranged immune regulation, Ann. N. Y. Acad. Sci. 276: 316.PubMedGoogle Scholar
  67. Lewis, M. G., Phillips, T. M., and Rowden, G., 1979, Host-tumour interactions as examples of enhancement and tolerance, in: Immunological Tolerance and Enhancement ( F. P. Stuart and F. W. Fitch, eds.), pp. 149–184, MTP Press, Lancaster, England.Google Scholar
  68. Margaretten, W., and McKay, D. G., 1971, The requirement of platelets in the active arthus reaction, Am.J. Pathol. 64: 257.PubMedGoogle Scholar
  69. Mastrangelo, M.J., Laucius, J. F., and Outzen, H. C., 1974, Fundamental concepts in tumor immunology: A brief review, Semin. Oncol. 1: 291.PubMedGoogle Scholar
  70. Minden, P., Odom, L. M., Tubergen, D. G., Hardtke, M. A., Sharpton, T. R., Rose, B., Zlotnick, A., and Carr, R. I., 1980, Immune complexes in children with leukemia: Relationship to disease characteristics and to antibody response to mycobacterium Bovis (BCG) in patients receiving BCG immunotherapy, Cancer 45: 460.PubMedGoogle Scholar
  71. Morton, D. L., Malmagren, R. A., Holmes, E. C., and Ketcham, A. S., 1968, Demonstration of antibodies against human malignant melanoma by immunofluorescence, Surgery 64: 233.PubMedGoogle Scholar
  72. Muller-Eberhard, H. J., 1976, The serum complement system, in: Textbook of Immunopathology ( P. A. Miescher and H. J. Muller-Eberhard, eds.), pp. 45–73, Grune and Stratton, New York.Google Scholar
  73. Nelson, R. A., 1953, The immune-adherence phenomenon: An immunologically specific reaction between microorgansims and erythrocytes leading to enhanced phagocytosis, Science 118: 733.PubMedGoogle Scholar
  74. Nisenoff, A., Hopper, J. E., and Spring, S. B., 1975, The Antibody Molecule, Academic Press, New York.Google Scholar
  75. Old, L. J., Boyse, E. A., Geering, G., and Oettgen, H. F., 1968, Serologic approaches to the study of cancer in animals and man, Cancer Res. 28: 1288.PubMedGoogle Scholar
  76. Olsen, J. L., Phillips, T. M., Lewis, M. G., and Solez, K., 1979, Malignant melanoma with renal dense deposits containing tumor antigens, Clin. Nephrol. 12: 74.Google Scholar
  77. Osterland, C. K., Harboe, M., and Kunkle, H. G., 1963, Anti-gammaglobulin factors inhuman sera revealed by enzymatic splitting of anti-Rh antibodies, Vox Sang. 8: 133.PubMedGoogle Scholar
  78. Panayi, G.S., Poston, R. N., and Corrigal, V., 1977, Inhibition of antibody-mediated lymphocyte cytotoxicity by aggregated human immunoglobulin, Ann. Rheum, Dis. 36 (Suppl): 159.Google Scholar
  79. Pascal, R. R., Iannaccone, P. M., Rollwagen, F. M., Harding, T. A., and Bennett, S. J., 1976, Electron microscopy and immunofluorescence of glomerular complex deposits in cancer patients, Cancer Res. 36: 43.PubMedGoogle Scholar
  80. Pesce, A. J., Phillips, T. M., Ooi, B.S., Evans, A., Shank, R. A., and Lewis, M. G., 1980, Immune complexes in transitional cell carcinoma, J. Urol 123: 486.PubMedGoogle Scholar
  81. Phillips, T. M., and Lewis, M. E., 1976, Immune reactions in patients with bladder and prostatic cancer, Aust. N. Zealand J. Surg. 48: 545.Google Scholar
  82. Phillips, T. M., and Lewis, M. G., 1980, Detection of circulating immune complexes by polyethylene glycol sedimentation and double countercurrent Immunoelectrophoresis, in: Serologic Analysis of Human Cancer Antigens ( S. A. Rosenberg, ed.), pp. 701–703, Academic Press, New York.Google Scholar
  83. Phillips, T. M., Queen, W. D., and Lewis, M. G., 1982, The significance of circulating immune complexes in patients with malignant melanoma, in: Melanoma Antigens and Antibodies ( R. A. Riesfeld and S. Ferrone, eds.), pp. 289–316, Plenum Press, New York.Google Scholar
  84. Phillips, T. M., Queen, W. D., More, N. S., and Thompson, A. M., 1985, Induction of anti- idiotypic antibodies by naturally occurring rheumatoid factor, Ann. N. Y. Acad Sci. (in press).Google Scholar
  85. Piessons, W. F., 1970, Evidence for human cancer immunity: A review, Cancer 26: 1212.Google Scholar
  86. Ratnoff, O. D., and Naff, G. B., 1967, The conversion of C′l to C′l-esterase by plasmin and trypsin, J. Exp. Med. 125: 337.PubMedGoogle Scholar
  87. Robbins, J., and Stetson, C. A., 1959, An effect of antigen-antibody interaction on blood coagulation, J. Exp. Med. 109: 1.PubMedGoogle Scholar
  88. Robins, R. A., and Baldwin, R. W., 1978, Immune complexes in cancer, Cancer Immunol. Immunotherapy 4: 1.Google Scholar
  89. Rowley, D. A., Fitch, E. W., Stuart, F. P., Kohler, H., andCosenza, H., 1973, Specific suppression of immune responses, Science 181: 1133.PubMedGoogle Scholar
  90. Schroeter, A. L., Conn, D. L., and Jordon, R. E., 1976, Immunoglobulin and complement deposition in skin of rheumatoid arthritis and systemic lupus erythematosus patients, Ann. Rheum. Dis. 35: 321.PubMedGoogle Scholar
  91. Shiku, H., Takahashi, T., Oettgen, H. F., and Old, L. J., 1976, Cell surface antigens of human malignant melanoma. II. Serologic typing with immune adherence assays and definition of two new surface antigens, J. Exp. Med. 144: 873.PubMedGoogle Scholar
  92. Sinclair, N. R., and Chan, P. L., 1971, Regulation of the immune response. IV. The role of the Fc-fragment in feedback inhibition by antibody, Adv. Exp. Med. Biol. 12: 609.Google Scholar
  93. Sjogren, H. O., Hellstrom, I., Bansal, S.C., and Hellstrom, K. E., 1971, Suggestive evidence that the “blocking antibodies” of tumor-bearing individuals may be antigen-antibody complexes, Proc. Natl. Acad. Sci USA 68: 1372.PubMedGoogle Scholar
  94. Snyder, H. W., Jones, F. R., Day, N. K., and Hardy, W. D., 1982, Isolation and characterization of circulating feline leukemia virus-immune complexes from plasma of persistently infected pet cats removed by ex vivo immunoadsorption, J Immunol. 128: 2726.PubMedGoogle Scholar
  95. Southam, C. M., 1967, Evidence for cancer specific antigens in mm, Proc. Exp. Tumor Res. 9: 1.Google Scholar
  96. Tan, E. M., and Kunkle, H. G., 1966, An immunofluorescent study of the skin lesions in systemic lupus erythematosus, Arthritis Rheum. 9: 37.PubMedGoogle Scholar
  97. Taylor, F. B., and Ward, P. A., 1967, Generation of chemotactic activity in rabbit serum by plasminogen-streptokinase mixtures, J. Exp. Med. 126: 149.PubMedGoogle Scholar
  98. Terman, D. S., 1979, Extensive necrosis of primary and metastatic canine breast adenocarcinoma after extracorporeal perfusion over S. aureus-Cowan I, Clin. Res. 27: 392.Google Scholar
  99. Terman, D. S., Yamamoto, T., Mattioli, M., Cook, G., Tillquist, R., Henry, J., Poser, R., and Daskal, Y., 1980, Extensive necrosis of spontaneous canine mammary adenocarcinoma after extracorporeal perfusion over S. aureus Cowan I, J. Immunol. 124: 795.PubMedGoogle Scholar
  100. Terman, D. S., Young, J. B., Shearer, W. T., Ayus, C., Lehane, D., Mattioli, C., Espada, R., Howell, J. F., Yamamoto, T., Zaleski, H. I.,Miller, L.,Frommer, P.,Feldman, L., Henry, J., Tilquist, R., Cook, G., and Daskal, Y., 1981, Preliminary observations of the effects on breast adenocarcinoma of plasma perfused over immobilized protein A, N. Engl. J. Med. 305: 1195.PubMedGoogle Scholar
  101. Theofîlopoulos, A. N., and Dixon, F. J., 1980, Immune complexes in human diseases, Am. J. Pathol 100: 529.PubMedGoogle Scholar
  102. Theofîlopoulos, A. N., Wilson, C. B., and Dixon, F. J., 1976, The Raji cell radioimmuneassay for detecting immune complexes in human sera, J. Clin. Invest. 57: 169.PubMedGoogle Scholar
  103. Thoman, M. L., Morgan, E. L., and Weigle, W. O., 1981, Fc fragment activation of lymphocytes. I. Fc fragments trigger Lyt l+2+3- T lymphocytes to release a helper T cell-replacing activity, J. Immunol 126: 632.PubMedGoogle Scholar
  104. Twomey, J. J., Rossen, R. D., Lewis, V. M., Laughter, A. H., and Douglas, C. C., 1976, Rheumatoid factor and tumor-host interaction, Proc. Natl Acad. Sci. USA 73: 2106.PubMedGoogle Scholar
  105. Uhr, J. Q., and Phillips, J. M., 1966, In vitro sensitization of phagocytes and lymphocytes by antigen-antibody complexes, Ann. N. Y. Acad. Sci. 129: 792.Google Scholar
  106. Vansnick, J. L., Vanroost, E., Markowetz, B., Cambiaso, C. L., and Masson, P. L., 1978, Enhancement by IgM rheumatoid factor of in vitro ingestion by macrophages and in vivo clearance of aggregated IgG or antigen-antibody complexes, Eur. J. Immunol 8: 279.Google Scholar
  107. Virella, G., Shuler, C. W., and Sherwood, T., 1983, Non-complement dependent adsorption of soluble immune complexes to human red cells, Clin. Exp. Immunol 54: 448.PubMedGoogle Scholar
  108. Von Pirquet, C. F., and Schick, B., 1905, Die Serum Krankheit, Deuticke, Leipzig.Google Scholar
  109. Waaler, E., 1940, On occurrence of factors in human serum activating specific agglutination of sheep red blood corpuscles, Acta Pathol Microbiol Scand. 17: 172.Google Scholar
  110. Waller, M., Curry, S., and Richard, A., 1968, Serological specificity of IgG and IgM antiglobulin antibodies in anti-Gm(a) antisera, Exp. Immunol 3: 631.Google Scholar
  111. Williams, R. C., Duncan, M. H., Tung, K. S. K., Stinton, E. R., Walker, L. C., and Greaves, M. F., 1983, Characterization of immune complexes in acute lymphoblastic leukemia, Clin. Exp. Immunol 54: 418.PubMedGoogle Scholar
  112. Yoshida, T. O., and Andersson, B., 1972, Evidence for a receptor recognizing antigen complexed immunoglobulin on the surface of activated mouse thymus lymphocytes, Scand. J. Immunol 1: 401.PubMedGoogle Scholar
  113. Young, J. B., Ayus, J. C., Miller, L. K., Divine, G. W., Frommer, J.P., Miller, R. R., and Terman, D. S., 1983, Cardiopulmonary toxicity in patients with breast carcinoma during plasma perfusion over immobilized protein A, Am. J. Med. 75: 278.PubMedGoogle Scholar
  114. Zimmerman, S. E., Smith, F. P., Phillips, T. M., Coffey, R. J., and Schein,P. S., 1982, Gastric carcinoma and thrombotic thrombocytopenic purpura: Association with plasma immune complex concentrations, Br. Med. J. 284: 1432.Google Scholar
  115. Zimmerman, T. S., 1974, The platelet in complement-blood coagulation interaction, Adv. Biosci 2: 1.Google Scholar
  116. Zubler, R. H., Lange, G., Lambert, P. H., and Miescher, P. A., 1976, Detection of immune complexes in unheated sera by modified 125I-Clq binding test: Effect of heating on the bonding of Clq by immune complexes and application of the test to systemic lupus erythematosus, J. Immunol 116:232.PubMedGoogle Scholar

Copyright information

© Plenum Press, New York 1985

Authors and Affiliations

  • Terence M. Phillips
    • 1
  • Thomas V. Holohan
    • 1
    • 2
  • Stefan Korac
    • 3
  • Newton S. More
    • 1
  • William D. Queen
    • 1
  1. 1.Immunochemistry LaboratoryGeorge Washington University Medical CenterUSA
  2. 2.Food and Drug AdministrationUnited States Public Health ServiceRockvilleUSA
  3. 3.Medical Oncology DivisionGeorgetown University HospitalUSA

Personalised recommendations